TenEleven Translocation2 gene mutations: A potential new molecular marker in malignant gliomas (Review)

ISSN： 1792-1074

Source： Oncology Letters, Vol.3, Iss.1, 2012-01, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group

By Pollack Ian Hamilton Ronald Burger Peter Brat Daniel Rosenblum Marc Murdoch Geoffrey Nikiforova Marina Holmes Emiko Zhou Tianni Cohen Kenneth Jakacki Regina

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 155-163

Springer Publishing Company

Access to resources Recommend Favorite

Recent Advances in Experimental Molecular Therapeutics for Malignant Gliomas

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 4, 2004-07 ,pp. : 347-361

Bentham Science Publishers

Access to resources Recommend Favorite

Tenascin-A Marker for the Malignant Potential of Preinvasive Breast Cancers

By Goepel C. Buchmann J. Schultka R. Koelbl H.

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 372-378

Elsevier

Access to resources Recommend Favorite

Association of telomerase gene hTERT polymorphism and malignant gliomas

By Carpentier Catherine Lejeune Julie Gros Florent Everhard Sibille Marie Yannick Kaloshi Gentian Laigle-Donadey Florence Hoang-Xuan Khe Delattre Jean-Yves Sanson Marc

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 249-253

Springer Publishing Company

Access to resources Recommend Favorite

Convection enhanced delivery for the treatment of malignant gliomas: symposium review

By Vogelbaum Michael

Journal of Neuro-Oncology, Vol. 73, Iss. 1, 2005-05 ,pp. : 57-69

Springer Publishing Company

Access to resources Recommend Favorite